Zoetis Inc Net Income
| ZTS Stock | USD 126.79 0.00 0.00% |
As of the 9th of February, Zoetis maintains the Standard Deviation of 2.29, market risk adjusted performance of (0.18), and Mean Deviation of 1.27. Relative to fundamental indicators, the technical analysis model lets you check existing technical drivers of Zoetis Inc, as well as the relationship between them. Please check out Zoetis Inc standard deviation, treynor ratio, as well as the relationship between the Treynor Ratio and potential upside to decide if Zoetis Inc is priced fairly, providing market reflects its latest price of 126.79 per share. Given that Zoetis Inc has information ratio of (0.11), we strongly advise you to confirm Zoetis Inc's prevalent market performance to make sure the company can sustain itself at a future point.
Zoetis Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 6.5283 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Income | 2.9 B | 3 B | |
| Net Income Applicable To Common Shares | 2.9 B | 3 B | |
| Net Income From Continuing Ops | 2.9 B | 1.5 B | |
| Net Income Per Share | 4.93 | 5.17 | |
| Net Income Per E B T | 0.71 | 0.58 |
Zoetis | Net Income | Build AI portfolio with Zoetis Stock |
The evolution of Net Income for Zoetis Inc provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Zoetis compares to historical norms and industry peers.
Latest Zoetis' Net Income Growth Pattern
Below is the plot of the Net Income of Zoetis Inc over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Zoetis Inc financial statement analysis. It represents the amount of money remaining after all of Zoetis Inc operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Zoetis' Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Zoetis' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 2.5 B | 10 Years Trend |
|
Net Income |
| Timeline |
Zoetis Net Income Regression Statistics
| Arithmetic Mean | 1,358,808,529 | |
| Coefficient Of Variation | 72.32 | |
| Mean Deviation | 844,525,675 | |
| Median | 1,428,000,000 | |
| Standard Deviation | 982,689,584 | |
| Sample Variance | 965678.8T | |
| Range | 3.1B | |
| R-Value | 0.98 | |
| Mean Square Error | 33387.6T | |
| R-Squared | 0.97 | |
| Slope | 191,421,716 | |
| Total Sum of Squares | 15450861.1T |
Zoetis Net Income History
Other Fundumenentals of Zoetis Inc
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Zoetis Net Income component correlations
Zoetis Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Zoetis is extremely important. It helps to project a fair market value of Zoetis Stock properly, considering its historical fundamentals such as Net Income. Since Zoetis' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Zoetis' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Zoetis' interrelated accounts and indicators.
Click cells to compare fundamentals
Is there potential for Pharmaceuticals market expansion? Will Zoetis introduce new products? Factors like these will boost the valuation of Zoetis. Anticipated expansion of Zoetis directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about Zoetis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.085 | Dividend Share 1.932 | Earnings Share 5.94 | Revenue Per Share | Quarterly Revenue Growth 0.005 |
The market value of Zoetis Inc is measured differently than its book value, which is the value of Zoetis that is recorded on the company's balance sheet. Investors also form their own opinion of Zoetis' value that differs from its market value or its book value, called intrinsic value, which is Zoetis' true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Zoetis' market value can be influenced by many factors that don't directly affect Zoetis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zoetis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Zoetis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Zoetis' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Zoetis 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Zoetis' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Zoetis.
| 11/11/2025 |
| 02/09/2026 |
If you would invest 0.00 in Zoetis on November 11, 2025 and sell it all today you would earn a total of 0.00 from holding Zoetis Inc or generate 0.0% return on investment in Zoetis over 90 days. Zoetis is related to or competes with Cencora, Regeneron Pharmaceuticals, IDEXX Laboratories, Haleon Plc, Cigna Corp, Elevance Health, and Becton Dickinson. Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic prod... More
Zoetis Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Zoetis' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Zoetis Inc upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.11) | |||
| Maximum Drawdown | 13.78 | |||
| Value At Risk | (2.42) | |||
| Potential Upside | 2.74 |
Zoetis Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Zoetis' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Zoetis' standard deviation. In reality, there are many statistical measures that can use Zoetis historical prices to predict the future Zoetis' volatility.| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.23) | |||
| Total Risk Alpha | (0.39) | |||
| Treynor Ratio | (0.19) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Zoetis' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Zoetis February 9, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.05) | |||
| Market Risk Adjusted Performance | (0.18) | |||
| Mean Deviation | 1.27 | |||
| Coefficient Of Variation | (1,471) | |||
| Standard Deviation | 2.29 | |||
| Variance | 5.23 | |||
| Information Ratio | (0.11) | |||
| Jensen Alpha | (0.23) | |||
| Total Risk Alpha | (0.39) | |||
| Treynor Ratio | (0.19) | |||
| Maximum Drawdown | 13.78 | |||
| Value At Risk | (2.42) | |||
| Potential Upside | 2.74 | |||
| Skewness | (2.98) | |||
| Kurtosis | 19.29 |
Zoetis Inc Backtested Returns
Currently, Zoetis Inc is very steady. Zoetis Inc shows Sharpe Ratio of 0.0755, which attests that the company had a 0.0755 % return per unit of risk over the last 3 months. We have found twenty-one technical indicators for Zoetis Inc, which you can use to evaluate the volatility of the company. Please check out Zoetis' Mean Deviation of 1.27, market risk adjusted performance of (0.18), and Standard Deviation of 2.29 to validate if the risk estimate we provide is consistent with the expected return of 0.12%. Zoetis has a performance score of 5 on a scale of 0 to 100. The firm maintains a market beta of 0.87, which attests to possible diversification benefits within a given portfolio. Zoetis returns are very sensitive to returns on the market. As the market goes up or down, Zoetis is expected to follow. Zoetis Inc right now maintains a risk of 1.52%. Please check out Zoetis Inc potential upside, and the relationship between the jensen alpha and accumulation distribution , to decide if Zoetis Inc will be following its historical returns.
Auto-correlation | 0.05 |
Virtually no predictability
Zoetis Inc has virtually no predictability. Overlapping area represents the amount of predictability between Zoetis time series from 11th of November 2025 to 26th of December 2025 and 26th of December 2025 to 9th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Zoetis Inc price movement. The serial correlation of 0.05 indicates that only as little as 5.0% of current Zoetis price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.05 | |
| Spearman Rank Test | 0.02 | |
| Residual Average | 0.0 | |
| Price Variance | 2.77 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Zoetis Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Zoetis Inc reported net income of 2.5 B. This is much higher than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The net income for all United States stocks is significantly lower than that of the firm.
Zoetis Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Zoetis' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Zoetis could also be used in its relative valuation, which is a method of valuing Zoetis by comparing valuation metrics of similar companies.Zoetis is currently under evaluation in net income category among its peers.
Zoetis ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Zoetis' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Zoetis' managers, analysts, and investors.Environmental | Governance | Social |
Zoetis Institutional Holders
Institutional Holdings refers to the ownership stake in Zoetis that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Zoetis' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Zoetis' value.| Shares | Goldman Sachs Group Inc | 2025-06-30 | 5.5 M | Norges Bank | 2025-06-30 | 5.2 M | Ubs Asset Mgmt Americas Inc | 2025-06-30 | 5.2 M | Bank Of New York Mellon Corp | 2025-06-30 | 4.9 M | Unisphere Establishment | 2025-06-30 | 4.8 M | Brown Advisory Holdings Inc | 2025-06-30 | 4.7 M | Deutsche Bank Ag | 2025-06-30 | 3.8 M | Mitsubishi Ufj Asset Management Co.,ltd | 2025-06-30 | 3.8 M | Alliancebernstein L.p. | 2025-06-30 | 3.7 M | Vanguard Group Inc | 2025-06-30 | 41.9 M | Blackrock Inc | 2025-06-30 | 37.2 M |
Zoetis Fundamentals
| Return On Equity | 0.5 | ||||
| Return On Asset | 0.15 | ||||
| Profit Margin | 0.28 % | ||||
| Operating Margin | 0.39 % | ||||
| Current Valuation | 61.35 B | ||||
| Shares Outstanding | 440.69 M | ||||
| Shares Owned By Institutions | 99.03 % | ||||
| Number Of Shares Shorted | 15.56 M | ||||
| Price To Earning | 43.89 X | ||||
| Price To Book | 10.40 X | ||||
| Price To Sales | 6.01 X | ||||
| Revenue | 9.26 B | ||||
| Gross Profit | 6.74 B | ||||
| EBITDA | 3.87 B | ||||
| Net Income | 2.5 B | ||||
| Cash And Equivalents | 1.99 B | ||||
| Cash Per Share | 5.88 X | ||||
| Total Debt | 6.74 B | ||||
| Debt To Equity | 1.48 % | ||||
| Current Ratio | 2.18 X | ||||
| Book Value Per Share | 12.23 X | ||||
| Cash Flow From Operations | 2.95 B | ||||
| Short Ratio | 2.78 X | ||||
| Earnings Per Share | 5.94 X | ||||
| Price To Earnings To Growth | 2.39 X | ||||
| Target Price | 152.81 | ||||
| Number Of Employees | 13.8 K | ||||
| Beta | 0.96 | ||||
| Market Capitalization | 56.47 B | ||||
| Total Asset | 14.24 B | ||||
| Retained Earnings | 11.97 B | ||||
| Working Capital | 2.57 B | ||||
| Current Asset | 3.83 B | ||||
| Current Liabilities | 1.78 B | ||||
| Annual Yield | 0.02 % | ||||
| Five Year Return | 0.55 % | ||||
| Net Asset | 14.24 B | ||||
| Last Dividend Paid | 1.93 |
About Zoetis Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Zoetis Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Zoetis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Zoetis Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Zoetis Stock Analysis
When running Zoetis' price analysis, check to measure Zoetis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zoetis is operating at the current time. Most of Zoetis' value examination focuses on studying past and present price action to predict the probability of Zoetis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zoetis' price. Additionally, you may evaluate how the addition of Zoetis to your portfolios can decrease your overall portfolio volatility.